๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Assessing biosimilarity and interchangeability of biosimilar products

โœ Scribed by Chow, Shein-Chung

Book ID
118767162
Publisher
John Wiley and Sons
Year
2013
Tongue
English
Weight
53 KB
Volume
32
Category
Article
ISSN
0277-6715

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Interchangeability, immunogenicity and b
Interchangeability, immunogenicity and biosimilars
โœ Ebbers, Hans C; Crow, Stacy A; Vulto, Arnold G; Schellekens, Huub ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Nature Publishing Group ๐ŸŒ English โš– 216 KB
Quality of Original and Biosimilar Epoet
Quality of Original and Biosimilar Epoetin Products
โœ Vera Brinks; Andrea Hawe; Abdul H. H. Basmeleh; Liliana Joachin-Rodriguez; Rob H ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Springer US ๐ŸŒ English โš– 332 KB

## Purpose To compare the quality of therapeutic erythropoietin (EPO) products, including two biosimilars, with respect to content, aggregation, isoform profile and potency. ## Methods Two original products, Eprex (epoetin alfa) and Dynepo (epoetin delta), and two biosimilar products, Binocrit (e

Analytical strategies for assessing comp
Analytical strategies for assessing comparability of biosimilars
โœ Robert J. Falconer; Dianne Jackson-Matthews; Stephen M. Mahler ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› Wiley (John Wiley & Sons) ๐ŸŒ English โš– 122 KB

## Abstract Biosimilar products are required by regulatory authorities to have appropriate and comparable quality, safety and efficacy with a reference biologic product. The analytical techniques that are available to manufacturers of biosimilar medicines are well advanced and present a range of op